Информация предназначена только для профессионалов в области здравоохранения.
Вы можете зайти как пользователь социальных сетей
1ФГБОУ ВО «Ставропольский государственный медицинский университет» Минздрава России, Ставрополь, Россия; 2Университет им. Давида Бен-Гуриона в Негеве, Беер-Шева, Израиль yubykov@gmail.com
Список исп. литературыСкрыть список 1. Amann B, Pantel J, Grunze H et al. Anticonvulsants in the treatment of aggression in the demented elderly: an update. Clin Pract Epidemiol Ment Health 2009; 5: 14. 2. American Psychiatry Association. Diagnostic And Statistical Manual Of Mental Disorders 5th edn. (DSM-5) Washington DC: American Psychiatry Association; 2013. 3. Aulakh JS, Hawkins JW, Athwal HS et al. Tolerability and effectiveness of lamotrigine in complex elderly patients. J Geriatr Psychiatry Neurol 2005; 18 (1): 8–11. 4. Berger SP, Winhusen TM, Somoza EC et al. A medication screening trial evaluation of reserpine, gabapentin and lamotrigine pharmacotherapy of cocaine dependence. Addiction 2005; 100 (Suppl. 1): 58–67. 5. Berkowitz AL, Semenchuk M. Effectiveness and tolerability of lamotrigine for acute agitation and aggression in dementia. 16th Annual Meeting American Association for Geriatric Psychiatry, Honolulu, Hawaii, 2003. 6. Betchel NT, Saadabadi A. Lamotrigine. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2017–2018. 7. Bisol LW, Lara DR. Improvement of obsessive-compulsive disorder with divalproex and lamotrigine in two patients with bipolar II disorder. Pharmacopsychiatry 2009; 42 (1): 37–9. 8. Bowden CL, Mitchell P, Suppes T. Lamotrigine in the treatment of bipolar depression. Eur Neuropsychopharmacol 1999; 9 (Suppl. 4): S113–S117. 9. Bowden CL, Singh V. Lamotrigine (Lamictal IR) for the treatment of bipolar disorder. Expert Opin Pharmacother 2012; 13 (17): 2565–71. 10. Bowen RC, Balbuena L, Baetz M. Lamotrigine reduces affective instability in depressed patients with mixed mood and anxiety disorders. J Clin Psychopharmacol 2014; 34 (6): 747–9. 11. Brown ES, Nejtek VA, Perantie DC et al. Lamotrigine in patients with bipolar disorder and cocaine dependence. J Clin Psychiatry 2003; 64: 197–201. 12. Brown ES, Perantie DC, Dhanani N et al. Lamotrigine for bipolar disorder and comorbid cocaine dependence: a replication and extension study. J Affect Disord 2006; 93: 219–22. 13. Bruno A, Micò U, Pandolfo G et al. Lamotrigine augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a double-blind, placebo-controlled study. J Psychopharmacol (Oxford) 2012; 26 (11): 1456–62. 14. Chang K, Saxena K, Howe M. An open-label study of lamotrigine adjunct or monotherapy for the treatment of adolescents with bipolar depression. J Am Acad Child Adolesc Psychiatry 2006; 45 (3): 298–304. 15. Cheung H, Kamp D, Harris E. An in vitro investigation of the action of lamotrigine on neuronal voltage-activated sodium channels. Epilepsy Res 1992; 13 (2): 107–12. 16. Cullen BA, Samuels JF, Bienvenu OJ et al. The relationship of pathologic skin picking to obsessive-compulsive disorder. J Nerv Ment Dis 2001; 189: 193–5. 17. Devarajan S, Dursun SM. Aggression in dementia with lamotrigine treatment. Am J Psychiatry 2000; 157 (7): 1178. 18. Frye MA, Watzl J, Banakar S et al. Increased anterior cingulate/medial prefrontal cortical glutamate and creatine in bipolar depression. Neuropsychopharmacology 2007; 32: 2490–9. 19. Grant JE, Odlaug BL, Chamberlain SR, Kim SW. A double-blind, placebo-controlled trial of lamotrigine for pathological skin picking: treatment efficacy and neurocognitive predictors of response. J Clin Psychopharmacol 2010; 30 (4): 396–403. 20. Grunze H, von Wegerer J, Greene RW, Walden J. Modulation of calcium and potassium currents by lamotrigine. Neuropsychobiology 1998; 38: 131–8. 21. Han SA, Yang EJ, Song MK, Kim SJ. Effects of lamotrigine on attention-deficit hyperactivity disorder in pediatric epilepsy patients. Korean J Pediatr 2017; 60 (6): 189–95. 22. Hanoglu L, Yulug B, Cakir T et al. The Therapeutic Role of Lamotrigine And Topiramate In A Depressive Patient With Anxiety Symptoms And Cognitive Decline: Neurometabolic Correlates. Curr Clin Pharmacol 2016. 23. Hertzberg MA, Butterfield M, Feldman ME et al. A preliminary study of lamotrigine for the treatment of posttraumatic stress disorder. Biol Psychiatry 1999; 45 (9): 1226–9. 24. Hussain A, Dar MA, Wani RA et al. Role of lamotrigine augmentation in treatment-resistant obsessive compulsive disorder: a retrospective case review from South Asia. Indian J Psychol Med 2015; 37 (2): 154–8. 25. Kalyoncu A, Mirsal H, Pektas O et al. Use of lamotrigine to augment clozapine in patients with resistant schizophrenia and comorbid alcohol dependence: a potent anti-craving effect? J Psychopharmacol 2005; 19 (3): 301–5. 26. Kato H, Fukatsu N, Noguchi T et al. Lamotrigine improves aggression in patients with temporal lobe epilepsy. Epilepsy Behav 2011; 21 (2): 173–6. 27. Khalkhali M, Aram S, Zarrabi H et al. Lamotrigine Augmentation Versus Placebo in Serotonin Reuptake Inhibitors-Resistant Obsessive-Compulsive Disorder: A Randomized Controlled Trial. Iran J Psychiatry 2016; 11 (2): 104–14. 28. Kishimoto A, Goto Y, Hashimoto K. Post-traumatic Stress Disorder Symptoms in a Female Patient Following Repeated Teasing: Treatment with Gabapentin and Lamotrigine and the Possible Role of Sensitization. Clin Psychopharmacol Neurosci 2014; 12 (3): 240–2. 29. Kozarić-Kovačić D, Eterović M. Lamotrigine abolished aggression in a patient with treatment-resistant posttraumatic stress disorder. Clin Neuropharmacol 2013; 36 (3): 94–5. 30. Labiner DM, Ettinger AB, Fakhoury TA et al. Effects of lamotrigine compared with levetiracetam on anger, hostility, and total mood in patients with partial epilepsy. Epilepsia 2009; 50 (3): 434–42. 31. Leiberich P, Nickel MK, Tritt K, Pedrosa Gil F. Lamotrigine treatment of aggression in female borderline patients, Part II: an 18-month follow-up. J Psychopharmacol 2008; 22 (7): 805–8. 32. Maina G, Albert U, Rosso G, Bogetto F. Olanzapine or lamotrigine addition to lithium in remitted bipolar disorder patients with anxiety disorder comorbidity: a randomized, single-blind, pilot study. J Clin Psychiatry 2008; 69 (4): 609–16. 33. Margolin A, Avants SK, DePhilippis D, Kosten TR. A preliminary investigation of lamotrigine for cocaine abuse in HIV-seropositive patients. Am J Drug Alcohol Abuse 1998; 24: 85–101. 34. Martinović Z, Buder N, Milovanović M, Velićković R. Antiepileptic, behavioral, and antidepressant effects of adjuvant lamotrigine therapy in drug-resistant epilepsy. Vojnosanit Pregl 2004; 61 (5): 485–90. 35. Masdrakis VG, Papadimitriou GN, Oulis P. Lamotrigine administration in panic disorder with agoraphobia. Clin Neuropharmacol 2010; 33 (3): 126–8. 36. Mirza NR, Bright JL, Stanhope KJ et al. Lamotrigine has an anxiolytic-like profile in the rat conditioned emotional response test of anxiety: a potential role for sodium channels? Psychopharmacology (Berl) 2005; 180 (1): 159–68. 37. Moretti M. [Trichotillomania and comorbidity – lamotrigine in a new perspective]. [Article in Hungarian]. Neuropsychopharmacol Hung 2008; 10 (4): 201–12. 38. Morton WA, Stockton GG. Methylphenidate Abuse and psychiatric side effects. Prim Care Companion J Clin Psychiatry 2000; 2: 159–64. 39. Naguy A, Alamiri B, Al-Khadhari S, Francis K. Lamotrigine augmentation in treatment-resistant pediatric obsessive-compulsive disorder with a 16 month follow-up. J Child Adolesc Psychopharmacol 2016; 26 (8): 769–72. 40. Ng B, Camacho A, Bardwell W, Sewell DD. Lamotrigine for agitation in older patients with dementia. Int Psychogeriatr 2009; 21 (1): 207–8. 41. Olive MF, Cleva RM, Kalivas PW, Malcolm RJ. Glutamatergic medications for the treatment of drug and behavioral addictions. Pharmacol Biochem Behav 2012; 100 (4): 801–10. 42. Öncü B, Er O, Çolak B, Nutt DJ. Lamotrigine for attention deficit-hyperactivity disorder comorbid with mood disorders: a case series. J Psychopharmacol 2014; 28 (3): 282–3. 43. Pachet A, Friesen S, Winkelaar D, Gray S. Beneficial behavioural effects of lamotrigine in traumatic brain injury. Brain Inj 2003; 17 (8): 715–22. 44. Pavlovic Z. Lamotrigine reduces craving and depressive symptoms in cocaine dependence. J Neuropsychiatry Clin Neurosci 2011; 23: E32. 45. Pavlovic ZM. Lamotrigine for the treatment of impulsive aggression and affective symptoms in a patient with borderline personality disorder comorbid with body dysmorphic disorder. J Neuropsychiatry Clin Neurosci 2008; 20 (1): 121–2. 46. Peters EM, Bowen R. Irritability in a mixed sample of patients with unipolar and bipolar II depression predicts responsiveness to lamotrigine. Personalized Medicine Psychiatry 2018; 7: 27–30. 47. Phelps P. Lamotrigine Update. Parts 1 and 2. www.psychopharmacologyinstitute.com 48. Pinto OC, Akiskal HS. Lamotrigine as a promising approach to borderline personality: an open case series without concurrent DSM-IV major mood disorder. J Affect Disord 1998; 51 (3): 333–43. 49. Preston GA, Marchant BK, Reimherr FW et al. Borderline personality disorder in patients with bipolar disorder and response to lamotrigine. J Affect Disord 2004; 79 (1–3): 297–303. 50. Reich DB, Zanarini MC, Bieri KA. A preliminary study of lamotrigine in the treatment of affective instability in borderline personality disorder. Int Clin Psychopharmacol 2009; 24 (5): 270–5. 51. Reid JG, Gitlin MJ, Altshuler LL. Lamotrigine in psychiatric disorders. J Clin Psychiatry 2013; 74 (7): 675–84. 52. Rihmer Z, Gonda X, Kálmán J. [Treatment of bipolar disorder with lamotrigine – relapse rate and suicidal behaviour during 6 month follow-up]. [Article in Hungarian]. Neuropsychopharmacol Hung 2015; 17 (1): 7–13. 53. Rubio G, Lopez-Munoz F, Alamo C. Effects of lamotrigine in patients with bipolar disorder and alcohol dependence. Bipolar Disord 2006; 8: 289–93. 54. Ruiz P. Comprehensive textbook of psychiatry. 2017. 55. Sepić-Grahovac D, Grahovac T, Ružić-Baršić A et al. Lamotrigine treatment of a patient affected by epilepsy and anxiety disorder. Psychiatr Danub 2011; 23 (1): 111–3. 56. Shen YC. Treatment of inhalant dependence with lamotrigine. Prog Neuropsychopharmacol Biol Psychiatry 2006; 31: 769–71. 57. Stahl's Essential Psychopharmacology: Neuroscientific Basis and Practical Applications. Cambridge University Press. 4rd Ed. 2013. 58. Suzuki H, Gen K. Clinical efficacy of lamotrigine and changes in the dosages of concomitantly used psychotropic drugs in Alzheimer's disease with behavioural and psychological symptoms of dementia: a preliminary open-label trial. Psychogeriatrics 2015; 15 (1): 32–7. 59. Tandon VR, Mahajan V, Gillani ZH, Mahajan A. Pregabalin-induced self-harm behavior. Indian J Pharmacol 2013; 45 (6): 638–9. 60. Tidwell A, Swims M. Review of the newer antiepileptic drugs. Am J Manag Care 2003; 9 (3): 253–76; quiz 277–9. 61. Tondo L, Baldessarini RJ. Suicidal Behavior in Mood Disorders: Response to Pharmacological Treatment. Curr Psychiatry Rep 2016; 18 (9): 88. 62. Trimble MR, Cull C. Children of school age: the influence of antiepileptic drugs on behavior and intellect. Epilepsia 1988; 29 (Suppl. 3): S15–S19. 63. Tritt K, Nickel C, Lahmann C et al. Lamotrigine treatment of aggression in female borderline-patients: a randomized, double-blind, placebo-controlled study. J Psychopharmacol 2005; 19 (3): 287–91. 64. Trunko ME, Schwartz TA, Berner LA et al. A pilot open series of lamotrigine in DBT-treated eating disorders characterized by significant affective dysregulation and poor impulse control. Borderline Personal Disord Emot Dysregul 2017; 4: 21. 65. Uvebrant P, Bauzienè R. Intractable epilepsy in children. The efficacy of lamotrigine treatment, including non-seizure-related benefits. Neuropediatrics 1994; 25: 284–9. 66. Uzun O. Lamotrigine as an augmentation agent in treatment-resistant obsessive-compulsive disorder: a case report. J Psychopharmacol (Oxford) 2010; 24 (3): 425–7. 67. Weiss SR, Post RM. Kindling separate vs. shared mechanisms in affective disorders and epilepsy. Neuropsychobiology 1998; 38: 167–80. 68. Weissenberger S, Ptacek R, Klicperova-Baker M. ADHD, Lifestyles and Comorbidities: A Call for an Holistic Perspective – from Medical to Societal Intervening Factors. Front Psychol 2017; 8: 454. 69. Whiting WL, Sullivan GA, Stewart JT. Lamotrigine Treatment for Agitation Following Traumatic Brain Injury. Psychosomatics 2016; 57 (3): 330–3. 70. Winther LC, Saleem R, McCance-Katz EF et al. Effects of lamotrigine on behavioral and cardiovascular responses to cocaine in human subjects. Am J Drug Alcohol Abuse 2000; 26: 47–59. 71. World Health Organization. Author; Geneva: 1992. The ICD-10 classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines, tenth revision.